Al-Litani, Karen, Ali, Tariq, Martinez, Pamela Robles and Buanz, Asma ORCID: 0000-0002-2556-1256 (2023) 3D printed implantable drug delivery devices for women’s health: formulation challenges and regulatory perspective. Advanced Drug Delivery Reviews, 198:114859. ISSN 0169-409X (Print), 1872-8294 (Online) (doi:https://doi.org/10.1016/j.addr.2023.114859)

Preview

PDF (Open Access Article) 48224 BUANZ_3D_Printed_Implantable_Drug_Delivery_Devices_For_Womens_Health_(OA)_2023.pdf - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

Modern pharmaceutical interventions are shifting from traditional “one-size-fits-all” approaches toward tailored therapies. Following the regulatory approval of Spritam®, the first marketed drug manufactured using three-dimensional printing (3DP) technologies, there is a precedence set for the use of 3DP in the manufacture of pharmaceutical products. The involvement of 3DP technologies in pharmaceutical research has demonstrated its capabilities in enabling the customisation of characteristics such as drug dosing, release characteristics and product designs on an individualised basis. Nonetheless, research into 3DP implantable drug delivery devices lags behind that for oral devices, cell-based therapies and tissue engineering applications.
The recent efforts and initiatives to address the disparity in women’s health is overdue but should provide a drive for more research into this area, especially using new and emerging technologies as 3DP. Therefore, the focus of this review has been placed on the unique opportunity of formulating personalised implantable drug delivery systems using 3DP for women’s health applications, particularly passive implants. An evaluation of the current landscape and key formulation challenges for achieving this is provided supplemented with critical insight into the current global regulatory status and its outlook.

Item Type:	Article
Uncontrolled Keywords:	additive manufacturing, localised therapy, biodegradable, non-biodegradable, women’s health, progesterone, estrogen, intrauterine obstetrics and gynaecology
Subjects:	Q Science > Q Science (General) Q Science > QD Chemistry
Faculty / School / Research Centre / Research Group:	Faculty of Engineering & Science Faculty of Engineering & Science > School of Science (SCI)
Last Modified:	01 Oct 2024 15:45
URI:	http://gala.gre.ac.uk/id/eprint/48224

Actions (login required)

View Item

Downloads